The invention relates to novel oxindole derivatives of general formula (I), wherein the substituents R
1
, R
2
, A, B, and Y are defined as in Claim
1
. The invention further relates to medicaments containing said derivatives, and use thereof for the prevention and/or treatment of vasopressin-dependent diseases.
本发明涉及一种一般式(I)的新型
噁唑啉衍
生物,其中取代基R1、R2、A、B和Y的定义如权利要求书所述。本发明还涉及含有该衍
生物的药物以及其用于预防和/或治疗利尿激素依赖性疾病的用途。